Venturi Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
+3,586
New +$300K 0.01% 482
2025
Q1
Sell
-2,683
Closed -$199K 972
2024
Q4
$199K Buy
2,683
+2,442
+1,013% +$171K 0.01% 547
2024
Q3
$15.9K Sell
241
-314
-57% -$22.8K ﹤0.01% 1081
2024
Q2
$51.3K Buy
555
+320
+136% +$28.3K ﹤0.01% 657
2024
Q1
$22.5K Buy
235
+47
+25% +$3.95K ﹤0.01% 705
2023
Q4
$14.3K Buy
188
+13
+7% +$905 ﹤0.01% 789
2023
Q3
$12.1K Buy
175
+52
+42% +$4.18K ﹤0.01% 761
2023
Q2
$11.6K Buy
123
+45
+58% +$3.91K ﹤0.01% 634
2023
Q1
$6.45K Buy
+78
New +$6.13K ﹤0.01% 784

Other funds holding EW

Venturi Wealth Management's EW Position: Q2 2026 in Review

Venturi Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,586 shares worth $324K. The stake represents 0.01% of the portfolio and ranks #482 among its holdings. This is a return to the name: Venturi Wealth Management previously reported a position in EW as recently as Q4 2024.

Venturi Wealth Management first reported a position in EW in Q1 2023 and has held it in 9 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Venturi Wealth Management held 3,586 shares of Edwards Lifesciences worth $324K as of Q2 2026.
  • Edwards Lifesciences was a new Venturi Wealth Management position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Venturi Wealth Management's portfolio in Q2 2026, its #482 holding.
  • Venturi Wealth Management first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 9 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.